You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

EVENTS

World Hemophilia Day 2021, Kedrion alongside patients

Today, more than ever, the company is close to those who are in a vulnerable condition

read more 

PLASMA & BIOTHERAPIES

Rh&Life, first subject included in the study

Two hundred pregnant women to be enrolled over five countries

read more 

PLASMA & BIOTHERAPIES

KIDCARES10, first patient enrolled in pediatric PI study

Thirty patients aged 2 to 17 years old to be enrolled over five European countries

read more 
  1. CORPORATE - 20-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 
  2. FEATURED STORIES - 04-01-2020

    In memory of Fabrizio Fabbrizzi

    Written by: Albert Farrugia

    read more 
  3. EVENTS - 25-11-2019

    Kedrion alongside IPOPI at the IPIC Congress in Madrid

    The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus

    read more 

Pages

For more information please contact: [email protected]